Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
HKSE - Delayed Quote HKD

Gushengtang Holdings Limited (2273.HK)

Compare
34.100
+0.100
+(0.29%)
At close: February 21 at 4:08:22 PM GMT+8
Loading Chart for 2273.HK
DELL
  • Previous Close 34.000
  • Open 34.200
  • Bid 33.900 x --
  • Ask 33.950 x --
  • Day's Range 33.000 - 35.100
  • 52 Week Range 25.500 - 49.900
  • Volume 2,874,792
  • Avg. Volume 2,006,691
  • Market Cap (intraday) 8.11B
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) 29.65
  • EPS (TTM) 1.150
  • Earnings Date --
  • Forward Dividend & Yield 0.26 (0.76%)
  • Ex-Dividend Date Sep 5, 2024
  • 1y Target Est 55.79

Gushengtang Holdings Limited, an investment holding company, provides healthcare services in the People's Republic of China. The company offers consultation, traditional massage, moxibustion, acupuncture, and other therapies. It is also involved in the wholesale of pharmaceutical products; and provision of investment management and supply chain management services. The company was formerly known as Gushengtang (Cayman) Ltd. and changed its name to Gushengtang Holdings Limited in September 2021. Gushengtang Holdings Limited was founded in 2010 and is headquartered in Guangzhou, the People's Republic of China.

www.gstzy.cn

2,895

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2273.HK

View More

Performance Overview: 2273.HK

Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

2273.HK
2.10%
HANG SENG INDEX
17.04%

1-Year Return

2273.HK
22.58%
HANG SENG INDEX
42.26%

3-Year Return

2273.HK
10.44%
HANG SENG INDEX
2.86%

5-Year Return

2273.HK
2.10%
HANG SENG INDEX
14.03%

Compare To: 2273.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2273.HK

View More

Valuation Measures

As of 2/21/2025
  • Market Cap

    8.11B

  • Enterprise Value

    7.24B

  • Trailing P/E

    29.57

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.90

  • Price/Book (mrq)

    3.26

  • Enterprise Value/Revenue

    2.51

  • Enterprise Value/EBITDA

    15.03

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.86%

  • Return on Assets (ttm)

    5.43%

  • Return on Equity (ttm)

    11.57%

  • Revenue (ttm)

    2.7B

  • Net Income Avi to Common (ttm)

    266.32M

  • Diluted EPS (ttm)

    1.150

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.17B

  • Total Debt/Equity (mrq)

    15.62%

  • Levered Free Cash Flow (ttm)

    347.83M

Research Analysis: 2273.HK

View More

People Also Watch